ArticleObesity science & practice2026

Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis.

Donna H Ryan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.